|
1
|
A systematic review highlights threats to validity in studies of barriers to cancer trial participation.
|
J Clin Epidemiol
|
2007
|
2.20
|
|
2
|
Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage.
|
J R Soc Med
|
2008
|
1.57
|
|
3
|
Increasing participation of cancer patients in randomised controlled trials: a systematic review.
|
Trials
|
2006
|
1.41
|
|
4
|
Palliative thoracic radiotherapy for non-small-cell lung cancer: a systematic review.
|
Am J Clin Oncol
|
2003
|
1.00
|
|
5
|
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer : a NICE single technology appraisal.
|
Pharmacoeconomics
|
2013
|
0.89
|
|
6
|
Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review.
|
Surg Infect (Larchmt)
|
2010
|
0.82
|
|
7
|
Psychosocial interventions for non-professional carers of people with Parkinson's disease: a systematic scoping review.
|
J Adv Nurs
|
2008
|
0.80
|
|
8
|
Guidelines for treatment of upper gastrointestinal cancer.
|
Lancet
|
2003
|
0.80
|
|
9
|
An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis?
|
Eur J Health Econ
|
2009
|
0.79
|